Clinical Trial Update: Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating IgY antibody from egg yolk for eradicating Helicobacter pylori and improving GI symptoms; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Diseases
• Helicobacter Pylori Infection

Drugs mentioned

• IgY antibody (immunoglobulin Y (IgY))

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: HELICOBACTER PYLORI INFECTIONS, Gastrointestinal Disease | Phase 2 | Status: COMPLETED